BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28813624)

  • 1. TP53 Mutational Status and ROS Effect the Expression of the Survivin-Associated Radio-Adaptive Response.
    Murley JS; Miller RC; Weichselbaum RR; Grdina DJ
    Radiat Res; 2017 Nov; 188(5):579-590. PubMed ID: 28813624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ROS modifiers and NOX4 affect the expression of the survivin-associated radio-adaptive response.
    Murley JS; Arbiser JL; Weichselbaum RR; Grdina DJ
    Free Radic Biol Med; 2018 Aug; 123():39-52. PubMed ID: 29660403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very low doses of ionizing radiation and redox associated modifiers affect survivin-associated changes in radiation sensitivity.
    Miller RC; Murley JS; Rademaker AW; Woloschak GE; Li JJ; Weichselbaum RR; Grdina DJ
    Free Radic Biol Med; 2016 Oct; 99():110-119. PubMed ID: 27427516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NFκB and Survivin-Mediated Radio-Adaptive Response.
    Grdina DJ; Murley JS; Miller RC; Woloschak GE; Li JJ
    Radiat Res; 2015 Apr; 183(4):391-7. PubMed ID: 25763931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualizing antimetabolic treatment strategies for head and neck squamous cell carcinoma based on TP53 mutational status.
    Sandulache VC; Skinner HD; Ow TJ; Zhang A; Xia X; Luchak JM; Wong LJ; Pickering CR; Zhou G; Myers JN
    Cancer; 2012 Feb; 118(3):711-21. PubMed ID: 21720999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of endogenous TP53 genomic status with clonogenicity and different modes of cell death after X irradiation.
    Lu-Hesselmann J; Abend M; van Beuningen D
    Radiat Res; 2004 Jan; 161(1):39-47. PubMed ID: 14680398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. siRNA targeting NBS1 or XIAP increases radiation sensitivity of human cancer cells independent of TP53 status.
    Ohnishi K; Scuric Z; Schiestl RH; Okamoto N; Takahashi A; Ohnishi T
    Radiat Res; 2006 Sep; 166(3):454-62. PubMed ID: 16972754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survivin-associated adaptive response in radiation therapy.
    Grdina DJ; Murley JS; Miller RC; Mauceri HJ; Sutton HG; Li JJ; Woloschak GE; Weichselbaum RR
    Cancer Res; 2013 Jul; 73(14):4418-28. PubMed ID: 23651635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosensitization, after a combined treatment of survivin siRNA and irradiation, is correlated with the activation of caspases 3 and 7 in a wt-p53 sarcoma cell line, but not in a mt-p53 sarcoma cell line.
    Kappler M; Taubert H; Bartel F; Blümke K; Panian M; Schmidt H; Dunst J; Bache M
    Oncol Rep; 2005 Jan; 13(1):167-72. PubMed ID: 15583820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG).
    Werbrouck C; Evangelista CCS; Lobón-Iglesias MJ; Barret E; Le Teuff G; Merlevede J; Brusini R; Kergrohen T; Mondini M; Bolle S; Varlet P; Beccaria K; Boddaert N; Puget S; Grill J; Debily MA; Castel D
    Clin Cancer Res; 2019 Nov; 25(22):6788-6800. PubMed ID: 31481512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionizing radiation enhances the expression of the nonsteroidal anti-inflammatory drug-activated gene (NAG1) by increasing the expression of TP53 in human colon cancer cells.
    Okazaki R; Moon Y; Norimura T; Eling T
    Radiat Res; 2006 Feb; 165(2):125-30. PubMed ID: 16435911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The different radiation response and radiation-induced bystander effects in colorectal carcinoma cells differing in p53 status.
    Widel M; Lalik A; Krzywon A; Poleszczuk J; Fujarewicz K; Rzeszowska-Wolny J
    Mutat Res; 2015 Aug; 778():61-70. PubMed ID: 26099456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [TcpC induces apoptosis of macrophages through promoting ROS production].
    Zhang DY; Lin YQ; He F; Fang J; Zhang C; Wang BM; Pan JP
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 42(5):486-91. PubMed ID: 24167127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of colorectal cancer cell lines treated with paclitaxel, radiation, and 5-FU: effect of TP53 or hMLH1 deficiency.
    Kennedy AS; Harrison GH; Mansfield CM; Zhou XJ; Xu JF; Balcer-Kubiczek EK
    Int J Cancer; 2000 Aug; 90(4):175-85. PubMed ID: 10993958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells.
    Zhou M; Gu L; Li F; Zhu Y; Woods WG; Findley HW
    J Pharmacol Exp Ther; 2002 Oct; 303(1):124-31. PubMed ID: 12235242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53 and TP53-related genes associated with protection from apoptosis in the radioadaptive response.
    Okazaki R; Ootsuyama A; Norimura T
    Radiat Res; 2007 Jan; 167(1):51-7. PubMed ID: 17214514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 in breast cancer subtypes and new insights into response to chemotherapy.
    Bertheau P; Lehmann-Che J; Varna M; Dumay A; Poirot B; Porcher R; Turpin E; Plassa LF; de Roquancourt A; Bourstyn E; de Cremoux P; Janin A; Giacchetti S; Espié M; de Thé H
    Breast; 2013 Aug; 22 Suppl 2():S27-9. PubMed ID: 24074787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of phosphorylation-defective survivin on radiation response in estrogen receptor-positive and -negative breast cancer.
    Debeb BG; Smith DL; Li L; Larson R; Xu W; Woodward WA
    PLoS One; 2015; 10(3):e0120719. PubMed ID: 25763854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines.
    Gock M; Mullins CS; Bergner C; Prall F; Ramer R; Göder A; Krämer OH; Lange F; Krause BJ; Klar E; Linnebacher M
    World J Gastroenterol; 2018 Nov; 24(43):4880-4892. PubMed ID: 30487698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ionizing radiation-induced gene expression changes in TP53 proficient and deficient glioblastoma cell lines.
    Godoy PR; Mello SS; Magalhães DA; Donaires FS; Nicolucci P; Donadi EA; Passos GA; Sakamoto-Hojo ET
    Mutat Res; 2013 Aug; 756(1-2):46-55. PubMed ID: 23817105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.